These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 36444449)

  • 1. [Progress in research of etiology and epidemiology of 2019-nCoV Omicron variant].
    Liao CX; Wang B; Lyu J; Li LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Nov; 43(11):1691-1698. PubMed ID: 36444449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in research of 2019-nCoV Omicron variant].
    Huang Y; Li YH; Xie SL; Rong ZH; Li BS; Kang M; Deng AP; Li Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 May; 43(5):655-662. PubMed ID: 35589568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.
    Armando F; Beythien G; Kaiser FK; Allnoch L; Heydemann L; Rosiak M; Becker S; Gonzalez-Hernandez M; Lamers MM; Haagmans BL; Guilfoyle K; van Amerongen G; Ciurkiewicz M; Osterhaus ADME; Baumgärtner W
    Nat Commun; 2022 Jun; 13(1):3519. PubMed ID: 35725735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of patients infected with 2019-nCoV Omicron variants BA.2 and BA.5 in Xi'an city, China].
    Shang FQ; Chen H; Yang X; Wu MJ; Wang FY; Ren F
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Dec; 45(12):1199-1203. PubMed ID: 36480850
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omicron variant of SARS-CoV-2 infection elicits cross-protective immunity in people who received boosters or infected with variant strains.
    Chowdhury S; Chowdhury MS; Chowdhury NS; Chowdhury S; Chowdhury S
    Int J Immunopathol Pharmacol; 2022; 36():3946320221133001. PubMed ID: 36214233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological characteristics of two local COVID-19 outbreaks caused by 2019-nCoV Omicron variant in Guangzhou, China].
    Huang Y; Zheng ZW; Chen C; Li K; Chen SY; Chen YY; Jing QL; Ma Y; Luo L; Yang ZC; Zhang ZB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Nov; 43(11):1705-1710. PubMed ID: 36444451
    [No Abstract]   [Full Text] [Related]  

  • 13. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
    Kannan S; Shaik Syed Ali P; Sheeza A
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
    Suzuki R; Yamasoba D; Kimura I; Wang L; Kishimoto M; Ito J; Morioka Y; Nao N; Nasser H; Uriu K; Kosugi Y; Tsuda M; Orba Y; Sasaki M; Shimizu R; Kawabata R; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; ; Sawa H; Ikeda T; Irie T; Matsuno K; Tanaka S; Fukuhara T; Sato K
    Nature; 2022 Mar; 603(7902):700-705. PubMed ID: 35104835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant.
    Ma W; Yang J; Fu H; Su C; Yu C; Wang Q; de Vasconcelos ATR; Bazykin GA; Bao Y; Li M
    Genomics Proteomics Bioinformatics; 2022 Feb; 20(1):60-69. PubMed ID: 35033679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.
    Zhang L; Li Q; Liang Z; Li T; Liu S; Cui Q; Nie J; Wu Q; Qu X; Huang W; Wang Y
    Emerg Microbes Infect; 2022 Dec; 11(1):1-5. PubMed ID: 34890524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.
    Shuai H; Chan JF; Hu B; Chai Y; Yuen TT; Yin F; Huang X; Yoon C; Hu JC; Liu H; Shi J; Liu Y; Zhu T; Zhang J; Hou Y; Wang Y; Lu L; Cai JP; Zhang AJ; Zhou J; Yuan S; Brindley MA; Zhang BZ; Huang JD; To KK; Yuen KY; Chu H
    Nature; 2022 Mar; 603(7902):693-699. PubMed ID: 35062016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.